CHRU Nîmes
CHRU Nîmes
Nîmes, France1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, central nervous system malformation, hereditary disease, hereditary sensory and autonomic neuropathy, inherited neurodegenerative disorder, megalencephaly-capillary malformation-polymicrogyria syndrome, nervous system disorder, neurodegenerative disease, neurodevelopmental disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, psychiatric disorder | Recruiting | Phase 2 | 2026-02-24 | NCT05577754 |